Abstract
BackgroundUrothelial pathogenesis is a complex process driven by an underlying network of interconnected genes. The identification of novel genomic target regions and gene targets that drive urothelial carcinogenesis is crucial in order to improve our current limited understanding of urothelial cancer (UC) on the molecular level. The inference of genome-wide gene regulatory networks (GRN) from large-scale gene expression data provides a promising approach for a detailed investigation of the underlying network structure associated to urothelial carcinogenesis.MethodsIn our study we inferred and compared three GRNs by the application of the BC3Net inference algorithm to large-scale transitional cell carcinoma gene expression data sets from Illumina RNAseq (179 samples), Illumina Bead arrays (165 samples) and Affymetrix Oligo microarrays (188 samples). We investigated the structural and functional properties of GRNs for the identification of molecular targets associated to urothelial cancer.ResultsWe found that the urothelial cancer (UC) GRNs show a significant enrichment of subnetworks that are associated with known cancer hallmarks including cell cycle, immune response, signaling, differentiation and translation. Interestingly, the most prominent subnetworks of co-located genes were found on chromosome regions 5q31.3 (RNAseq), 8q24.3 (Oligo) and 1q23.3 (Bead), which all represent known genomic regions frequently deregulated or aberated in urothelial cancer and other cancer types. Furthermore, the identified hub genes of the individual GRNs, e.g., HID1/DMC1 (tumor development), RNF17/TDRD4 (cancer antigen) and CYP4A11 (angiogenesis/ metastasis) are known cancer associated markers. The GRNs were highly dataset specific on the interaction level between individual genes, but showed large similarities on the biological function level represented by subnetworks. Remarkably, the RNAseq UC GRN showed twice the proportion of significant functional subnetworks. Based on our analysis of inferential and experimental networks the Bead UC GRN showed the lowest performance compared to the RNAseq and Oligo UC GRNs.ConclusionTo our knowledge, this is the first study investigating genome-scale UC GRNs. RNAseq based gene expression data is the data platform of choice for a GRN inference. Our study offers new avenues for the identification of novel putative diagnostic targets for subsequent studies in bladder tumors.Electronic supplementary materialThe online version of this article (doi:10.1186/s12918-015-0165-z) contains supplementary material, which is available to authorized users.
Highlights
Urothelial pathogenesis is a complex process driven by an underlying network of interconnected genes
The giant connected component of the inferred RNAseq urothelial cancer (UC) gene regulatory networks (GRN) consisted of 18,952 genes, the Bead UC GRN of 20,140 genes and the Oligo UC consisted of 12,492 genes (Figure 1A)
The edge density (d ∼ 0.001) of the Oligo has a slightly higher edge density compared to the RNAseq and Bead UC GRN
Summary
Urothelial pathogenesis is a complex process driven by an underlying network of interconnected genes. The identification of novel genomic target regions and gene targets that drive urothelial carcinogenesis is crucial in order to improve our current limited understanding of urothelial cancer (UC) on the molecular level. The inference of genome-wide gene regulatory networks (GRN) from large-scale gene expression data provides a promising approach for a detailed investigation of the underlying network structure associated to urothelial carcinogenesis. System-based approaches allow us to investigate the underlying network structure associated with carcinogenesis and facilitate a novel perspective for the identification of molecular targets that drive urothelial carcinogenesis. The inference of gene regulatory networks (GRN) from large-scale gene expression data of tumor samples from various grades and stages is a promising approach for the identification of novel putative targets in cancer [4,5,6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have